It is well-known that damage to the gastrointestinal tract wall by cytotoxic therapy, irradiation, or graft-versus-host disease enables translocation of the GM from the GI lumen into the blood, which may be partially responsible for the high false-positive rate of this assay (Matsudomi et al., 2002).